Skip to main content
. Author manuscript; available in PMC: 2008 Mar 30.
Published in final edited form as: Neurosci Lett. 2007 Jan 14;415(3):264–268. doi: 10.1016/j.neulet.2007.01.028

Fig. 3.

Fig. 3

Transgenic ALS rats show a delayed symptomatic disease onset and lifespan compared to previous reports. Post-symptomatic disease progression based on a modified 5-point motor score (a). Kaplan-Meier survival curves depict the symptomatic disease onset (DO) and the end-stage (ES) (b). wt, wild-type littermates (n=6). ALS, transgenic ALS rats (n=10). Male: female ratio is 1:1 in both groups. Black arrow represents the average age of symptomatic disease onset (167.6 days). *p < 0.05. ** p < 0.01. ***p < 0.001. + p = 0.0703.